Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections.
Humans
COVID-19
/ immunology
SARS-CoV-2
/ immunology
Health Personnel
Adult
Male
Female
Middle Aged
Risk Factors
Germany
/ epidemiology
Antibodies, Viral
/ blood
COVID-19 Vaccines
/ immunology
Prospective Studies
Reinfection
/ immunology
Seroepidemiologic Studies
Vaccination
Young Adult
Aged
Adolescent
Breakthrough Infections
COVID-19
ORCHESTRA
SARS-CoV-2
antibodies
breakthrough infections
health care workers
immunologic response
reinfections
seroprevalence
vaccination
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
30 Sep 2024
30 Sep 2024
Historique:
received:
26
07
2024
revised:
09
09
2024
accepted:
25
09
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
26
10
2024
Statut:
epublish
Résumé
This study analyzes immune responses to SARS-CoV-2 vaccination and infection, including asymptomatic cases, focusing on infection risks during the Omicron wave, particularly among high-risk healthcare workers. In the KoCo-Impf study, we monitored 6088 vaccinated participants in Munich aged 18 and above. From 13 May to 31 July 2022, 2351 participants were follow-uped. Logistic regression models evaluated primary, secondary, and breakthrough infections (BTIs). Roche Elecsys
Identifiants
pubmed: 39459890
pii: v16101556
doi: 10.3390/v16101556
pii:
doi:
Substances chimiques
Antibodies, Viral
0
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : European Union
ID : Grant Agreement No. 101016167